Key result
KDR polymorphism rs2071559 links to greater CIMT and plaque thickness in T2DM patients.
Why the study?
The study was designed to investigate possible associations between VEGF and KDR gene polymorphisms and markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
Are VEGF (rs2010963) and KDR (rs2071559) gene polymorphisms associated with markers of carotid atherosclerosis in patients with type 2 diabetes mellitus?
Case-Control (n=795)
Are VEGF (rs2010963) and KDR (rs2071559) gene polymorphisms associated with markers of carotid atherosclerosis in patients with type 2 diabetes mellitus?
The KDR gene polymorphism rs2071559 has a minor effect on markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
Hypothesis-generating for KDR rs2071559 in T2DM vasculopathy; should not change practice and needs prospective validation.
Background. The current study was designed to reveal possible associations between the polymorphisms of the vascular endothelial growth factor (VEGF) gene (rs2010963) and its receptor, kinase insert domain-containing receptor (KDR) gene polymorphism (rs2071559), and markers of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Patients and Methods. 595 T2DM subjects and 200 control subjects were enrolled. The carotid intima-media thickness (CIMT) and plaque characteristics (presence and structure) were assessed ultrasonographically. Biochemical analyses were performed using standard biochemical methods. Genotyping of VEGF/KDR polymorphisms (rs2010963, rs2071559) was performed using KASPar assays. Results. Genotype distributions and allele frequencies of the VEGF/KDR polymorphisms (rs2010963, rs2071559) were not statistically significantly different between diabetic patients and controls. In our study, we demonstrated an association between the rs2071559 of KDR and either CIMT or the sum of plaque thickness in subjects with T2DM. We did not, however, demonstrate any association between the tested polymorphism of VEGF (rs2010963) and either CIMT, the sum of plaque thickness, the number of involved segments, hsCRP, the presence of carotid plaques, or the presence of unstable carotid plaques. Conclusions. In the present study, we demonstrated minor effect of the rs2071559 of KDR on markers of carotid atherosclerosis in subjects with T2DM.
No takes yet. Share an insight, caveat, or question.
Merlo et al. (2015) conducted a case-control in Type 2 diabetes mellitus (n=795). VEGF (rs2010963) and KDR (rs2071559) gene polymorphisms vs. Control subjects was evaluated on Genotype distributions, allele frequencies, and markers of carotid atherosclerosis (CIMT and plaque characteristics). The KDR gene polymorphism rs2071559 was associated with carotid intima-media thickness and plaque thickness in T2DM patients, whereas VEGF rs2010963 showed no such associations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: